Lord, Abbett & Co. LLC Jazz Pharmaceuticals PLC Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $28.3 Million - $37 Million	-240,426 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $866,996 - $992,080	-6,926 Reduced 2.8%	240,426 $30.8 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $2.71 Million - $3.12 Million	-21,620 Reduced 8.04%	247,352 $35.3 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $6.21 Million - $7.29 Million	51,014 Added 23.41%	268,972 $38.5 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $20.9 Million - $30.1 Million	180,447 Added 481.05%	217,958 $27 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $2.34 Million - $2.62 Million	14,505 Added 63.05%	37,511 $6.31 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $3.37 Million - $4.21 Million	23,006 New	23,006 $3.96 Million

511

57.8M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.